These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9815801)
1. Comparison of oncogene mutation detection and telomerase activity for the molecular staging of non-small cell lung cancer. Ahrendt SA; Yang SC; Wu L; Westra WH; Jen J; Califano JA; Sidransky D Clin Cancer Res; 1997 Jul; 3(7):1207-14. PubMed ID: 9815801 [TBL] [Abstract][Full Text] [Related]
2. Telomerase activity and expression of the telomerase catalytic subunit gene in non-small cell lung cancer: correlation with decreased apoptosis and clinical prognosis. Wang J; Liu X; Jiang W; Liang L Chin Med J (Engl); 2000 Nov; 113(11):985-90. PubMed ID: 11776132 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases. Hashimoto T; Kobayashi Y; Ishikawa Y; Tsuchiya S; Okumura S; Nakagawa K; Tokuchi Y; Hayashi M; Nishida K; Hayashi S; Hayashi J; Tsuchiya E Cancer Res; 2000 Nov; 60(22):6472-8. PubMed ID: 11103815 [TBL] [Abstract][Full Text] [Related]
4. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence. Sanchez-Cespedes M; Esteller M; Hibi K; Cope FO; Westra WH; Piantadosi S; Herman JG; Jen J; Sidransky D Clin Cancer Res; 1999 Sep; 5(9):2450-4. PubMed ID: 10499618 [TBL] [Abstract][Full Text] [Related]
5. Analysis of mutant p53 and telomerase activity in non-small cell lung cancer. Kiyooka K; Maniwa Y; Okada M Ann Thorac Cardiovasc Surg; 1999 Oct; 5(5):293-9. PubMed ID: 10550714 [TBL] [Abstract][Full Text] [Related]
6. Study of telomerase activity in pleural lavage fluid specimens in patients with non-small-cell lung cancer and its clinical significance. Li W; Ni Y; Tu Z; Wu S; Wu Z; Zheng S Eur J Cardiothorac Surg; 2009 Sep; 36(3):460-4. PubMed ID: 19502078 [TBL] [Abstract][Full Text] [Related]
7. Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas. Kumaki F; Kawai T; Hiroi S; Shinomiya N; Ozeki Y; Ferrans VJ; Torikata C Hum Pathol; 2001 Feb; 32(2):188-95. PubMed ID: 11230706 [TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological study on nodal molecular staging of non-small-cell lung cancer]. Wang YX; Sun YE; Li XH; Wang ZB; Liu YL; Chen LA; Zhang GK Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):161-4. PubMed ID: 17425845 [TBL] [Abstract][Full Text] [Related]
9. [Comparative study for detecting micrometastases of lymph nodes in patients with lung cancer]. Wang YX; Sun YE; Li XH; Wang ZB; Liu YL; Chen LA; Tong XY Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):19-21. PubMed ID: 18346373 [TBL] [Abstract][Full Text] [Related]
10. Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study. Fernando HC; Sasatomi E; Christie NA; Buenaventura PO; Finkelstein SD; Yousem SA; Soose R; Close JM; Luketich JD J Thorac Cardiovasc Surg; 2004 Jan; 127(1):87-91. PubMed ID: 14752417 [TBL] [Abstract][Full Text] [Related]
11. Rapid diagnosis of lymph node metastasis in lung cancer with loop-mediated isothermal amplification assay using carcinoembryonic antigen-mRNA. Maeda J; Inoue M; Nakabayashi K; Otomo Y; Shintani Y; Ohta M; Okumura M; Matsuura N Lung Cancer; 2009 Sep; 65(3):324-7. PubMed ID: 19144442 [TBL] [Abstract][Full Text] [Related]
12. Telomerase activity and Bcl-2 expression in non-small cell lung cancer. Ohmura Y; Aoe M; Andou A; Shimizu N Clin Cancer Res; 2000 Aug; 6(8):2980-7. PubMed ID: 10955774 [TBL] [Abstract][Full Text] [Related]
13. A novel molecular staging protocol for non-small cell lung cancer. Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061 [TBL] [Abstract][Full Text] [Related]
14. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer. Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359 [TBL] [Abstract][Full Text] [Related]
15. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma. Jassem J; Jassem E; Jakóbkiewicz-Banecka J; Rzyman W; Badzio A; Dziadziuszko R; Kobierska-Gulida G; Szymanowska A; Skrzypski M; Zylicz M Cancer; 2004 May; 100(9):1951-60. PubMed ID: 15112277 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of occult lymph node metastases in non-small cell lung cancer: anatomical pathology results from Cancer and Leukemia Group B Trial 9761. Vollmer RT; Herndon JE; D'Cunha J; Abraham NZ; Solberg J; Fatourechi M; Maruska A; Kern JA; Green MR; Kratzke RA; Maddaus MA; Clin Cancer Res; 2003 Nov; 9(15):5630-5. PubMed ID: 14654545 [TBL] [Abstract][Full Text] [Related]
17. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer. Marchetti A; Bertacca G; Buttitta F; Chella A; Quattrocolo G; Angeletti CA; Bevilacqua G Clin Cancer Res; 1999 Aug; 5(8):2077-81. PubMed ID: 10473089 [TBL] [Abstract][Full Text] [Related]
18. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma. Werle B; Kraft C; Lah TT; Kos J; Schanzenbächer U; Kayser K; Ebert W; Spiess E Cancer; 2000 Dec; 89(11):2282-91. PubMed ID: 11147599 [TBL] [Abstract][Full Text] [Related]